2,6-Diaminopurine Induces ACTN3 Premature Termination Codon Readthrough

Area of Science:

• Genetics
• Molecular Biology
• Sports Science

Background:

• The ACTN3 gene encodes α-actinin-3, crucial for fast-twitch muscle fibers.
• A common R577X polymorphism leads to a non-functional protein due to premature termination.
• This deficiency is linked to reduced athletic performance and muscle mass.

Purpose of the Study:

• To investigate the potential of 2,6-diaminopurine (DAP) to restore functional α-actinin-3 protein from the ACTN3 R577X variant.
• To compare DAP's efficacy with previous methods using aminoglycoside antibiotics.

Main Methods:

• Utilized expression plasmids and HEK293 cultured cells.
• Administered 2,6-diaminopurine (DAP) at low concentrations (µM levels).
• Analyzed protein production and dimerization characteristics.

Main Results:

• DAP successfully induced translational readthrough of the ACTN3 577X premature termination codon.
• Full-length α-actinin-3 protein was produced from the ACTN3 577X gene using DAP alone.
• DAP-treated ACTN3 577X proteins showed increased homodimer formation compared to ACTN3 577R proteins.

Conclusions:

• 2,6-diaminopurine (DAP) demonstrates potential for restoring ACTN3 gene function.
• DAP offers a promising therapeutic strategy for individuals with the ACTN3 R577X genotype.
• This approach could enhance muscle function and athletic performance in affected individuals.